Tuesday, April 12, 2005

Morning Buy/Sell Recommendations

Goldman Sachs:
- Reiterated Outperform on DNA, COF and GCI.
- Reiterated Underperform on PBG.

Smith Barney:
- Reiterated Buy on DNA, target $87.50.
- Reiterated Sell on IMCL, target $36.
- Reiterated Buy on CELG, target $41.
- Reiterated Buy on LRCX, target $38.

Morgan Stanley:
- Raised TLWT to Overweight, target $23.

JP Morgan:
- Cut WDC to Underweight.
- Rated GBBK Underweight.
- Raised SHW to Overweight.
- Rated PCBC Overweight.

Banc of America:
- Rated ALB Buy, target $41.

CSFB:
- Downgraded SKS to Underperform, target $14.

CIBC:
- Raised NICE to Sector Outperform, target $46.

Legg Mason:
- Rated WYNN Buy, target $80.

Merrill Lynch:
- Raised CUNO to Buy, target $60.
- Raised CSCO to Buy and added to Focus 1 stock list.

UBS:
- Rated URS Buy, target $45.
- Rated MHS Buy, target $67.
- Raised UGI to Buy, target $56.
- Reiterated Buy on OTEX, target $22.
- Reiterated Reduce on BMC, target $14.

Bear Stearns:
- Reiterated Outperform on HET, target $83.

Prudential:
- Reiterated Overweight on PD, target $137.

No comments: